| RS137853329 |
IKBKG
|
Health Risk |
Pathogenic |
Ectodermal dysplasia and immunodeficiency 1, Ectodermal dysplasia and immunodeficiency 1 |
| RS137853330 |
IKBKG
|
Health Risk |
Pathogenic |
Ectodermal dysplasia and immunodeficiency 1, Ectodermal dysplasia and immunodeficiency 1 |
| RS137853331 |
IKBKG
|
Health Risk |
Likely pathogenic |
Immunodeficiency 33, Immunodeficiency 33 |
| RS137853332 |
IKBKG
|
Health Risk |
Pathogenic |
Immunodeficiency 33, Immunodeficiency 33 |
| RS137853333 |
KCNMA1
|
Health Risk |
Pathogenic |
Generalized epilepsy-paroxysmal dyskinesia syndrome, Generalized epilepsy-paroxysmal dyskinesia syndrome |
| RS137853334 |
HNF4A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 1, Monogenic diabetes |
| RS137853335 |
HNF4A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 1, Monogenic diabetes |
| RS137853336 |
HNF4A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 1, Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young |
| RS137853338 |
HNF4A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 1, Monogenic diabetes |
| RS137853339 |
GCNT2
|
Health Risk |
Pathogenic |
ADULT i BLOOD GROUP PHENOTYPE, ADULT i BLOOD GROUP PHENOTYPE |
| RS137853340 |
GCNT2
|
Health Risk |
Pathogenic |
ADULT i BLOOD GROUP PHENOTYPE, ADULT i BLOOD GROUP PHENOTYPE |
| RS137853342 |
SCNN1G
|
Health Risk |
Pathogenic |
Liddle syndrome 2, Liddle syndrome 2 |
| RS137853579 |
IL10RA
|
Health Risk |
Pathogenic |
Inflammatory bowel disease 28, Inflammatory bowel disease 28 |
| RS137853580 |
IL10RA
|
Health Risk |
Pathogenic |
Inflammatory bowel disease 28, Inflammatory bowel disease 28 |
| RS137853583 |
GPI
|
Health Risk |
Pathogenic/Likely pathogenic |
Hemolytic anemia due to glucophosphate isomerase deficiency, Hemolytic anemia due to glucophosphate isomerase deficiency |
| RS137853584 |
GPI
|
Health Risk |
Conflicting classifications of pathogenicity |
Hemolytic anemia due to glucophosphate isomerase deficiency, Inborn genetic diseases |
| RS137853585 |
GPI
|
Health Risk |
Pathogenic |
Hemolytic anemia due to glucophosphate isomerase deficiency, Hemolytic anemia due to glucophosphate isomerase deficiency |
| RS137853586 |
GPI
|
Health Risk |
Pathogenic |
Hemolytic anemia due to glucophosphate isomerase deficiency, Hemolytic anemia due to glucophosphate isomerase deficiency |
| RS137853587 |
GPI
|
Health Risk |
Pathogenic |
Hemolytic anemia due to glucophosphate isomerase deficiency, Hemolytic anemia due to glucophosphate isomerase deficiency |
| RS137853588 |
PHKG2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXc, Glycogen storage disease IXc |
| RS137853589 |
PHKG2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXc, Glycogen storage disease IXc |
| RS137853590 |
PHKG2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXc, Glycogen storage disease IXc |
| RS137853591 |
PHKG2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXc, Glycogen storage disease IXc |
| RS137853592 |
PHKG2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXc, Glycogen storage disease IXc |
| RS137853593 |
ASAH1
|
Health Risk |
Pathogenic |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS137853594 |
ASAH1
|
Health Risk |
Likely pathogenic |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS137853595 |
ASAH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS137853596 |
ASAH1
|
Health Risk |
Pathogenic |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS137853597 |
ASAH1
|
Health Risk |
Pathogenic |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS137853598 |
C1GALT1C1
|
Health Risk |
Pathogenic |
Polyagglutinable erythrocyte syndrome, Polyagglutinable erythrocyte syndrome |
| RS137853599 |
C1GALT1C1
|
Health Risk |
Pathogenic |
Polyagglutinable erythrocyte syndrome, Polyagglutinable erythrocyte syndrome |
| RS137853825 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS137853829 |
OCRL
|
Health Risk |
Likely pathogenic |
Lowe syndrome, Dent disease type 2 |
| RS137853831 |
OCRL
|
Health Risk |
Conflicting classifications of pathogenicity |
Lowe syndrome, Lowe syndrome |
| RS137853846 |
OCRL
|
Health Risk |
Pathogenic |
Dent disease type 2, Lowe syndrome |
| RS137853852 |
OCRL
|
Health Risk |
Likely pathogenic |
Lowe syndrome, Lowe syndrome |
| RS137853858 |
OCRL
|
Health Risk |
Pathogenic |
Lowe syndrome, Lowe syndrome |
| RS137853859 |
GALE
|
Health Risk |
Pathogenic/Likely pathogenic |
UDPglucose-4-epimerase deficiency, See cases |
| RS137853860 |
GALE
|
Health Risk |
Pathogenic/Likely pathogenic |
UDPglucose-4-epimerase deficiency, Thrombocytopenia 13 |
| RS137853861 |
GALE
|
Health Risk |
Likely pathogenic |
UDPglucose-4-epimerase deficiency, Thrombocytopenia 13 |
| RS137853863 |
NSDHL
|
Health Risk |
Likely pathogenic |
Child syndrome, Child syndrome |
| RS137853865 |
PPIB
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 9, Osteogenesis imperfecta type 9 |
| RS137853866 |
PPIB
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type 9, Osteogenesis imperfecta |
| RS137853867 |
PPIB
|
Health Risk |
Pathogenic |
— |
| RS137853869 |
PPIB
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 9, Osteogenesis imperfecta |
| RS137853882 |
FKBP10
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 12, Osteogenesis imperfecta type 12 |
| RS137853883 |
FKBP10
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 12, Bruck syndrome 1 |
| RS137853884 |
FKBP10
|
Health Risk |
Pathogenic |
Bruck syndrome 1, FKBP10-related disorder |
| RS137853890 |
P3H1
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS137853892 |
SERPINH1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 10, Osteogenesis imperfecta type 10 |
| RS137853893 |
SP7
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 12, Osteogenesis imperfecta type 12 |
| RS137853898 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS137853899 |
PDE6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS137853905 |
BEST1
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS137853907 |
PROM1
|
Health Risk |
Pathogenic |
Retinal dystrophy, Cone-rod dystrophy 12 |
| RS137853909 |
MKKS
|
Health Risk |
Conflicting classifications of pathogenicity |
McKusick-Kaufman syndrome, Bardet-Biedl syndrome 6 |
| RS137853917 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2C, Usher syndrome type 2C |
| RS137853921 |
BBS5
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone dystrophy, Bardet-Biedl syndrome |
| RS137853922 |
TTC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Bardet-Biedl syndrome |
| RS137853923 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 39 |
| RS137853924 |
CRYGC
|
Health Risk |
Pathogenic |
Cataract 2, multiple types |
| RS137853928 |
CRLF1
|
Health Risk |
Pathogenic |
Cold-induced sweating syndrome 1, Cold-induced sweating syndrome 1 |
| RS137853929 |
CRLF1
|
Health Risk |
Pathogenic |
Cold-induced sweating syndrome 1, Cold-induced sweating syndrome |
| RS137853932 |
CRLF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cone-rod dystrophy 12, Cold-induced sweating syndrome 1 |
| RS137853933 |
CRLF1
|
Health Risk |
Likely pathogenic |
Cold-induced sweating syndrome 1, Cold-induced sweating syndrome 1 |
| RS137853934 |
CLCF1
|
Health Risk |
Pathogenic |
Cold-induced sweating syndrome 2, Cold-induced sweating syndrome 2 |
| RS137853935 |
CLCF1
|
Health Risk |
Pathogenic |
Cold-induced sweating syndrome 2, Cold-induced sweating syndrome 2 |
| RS137853936 |
CRTAP
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS137853939 |
CRTAP
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta |
| RS137853940 |
CRTAP
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS137853941 |
CRTAP
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS137853943 |
CRTAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta |
| RS137853944 |
CRTAP
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS137853946 |
CRTAP
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS137853947 |
CRTAP
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS137853948 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS137853950 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS137853952 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS137853953 |
P3H1
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS137853961 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS137853965 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS137853966 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypercholesterolemia, familial |
| RS137853967 |
ATP13A2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS137853969 |
KCNQ4
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 2A, Autosomal dominant nonsyndromic hearing loss 2A |
| RS137853970 |
USB1
|
Health Risk |
Pathogenic |
Poikiloderma with neutropenia, Poikiloderma with neutropenia |
| RS137853971 |
USB1
|
Health Risk |
Pathogenic |
Poikiloderma with neutropenia, Poikiloderma with neutropenia |
| RS137853972 |
USB1
|
Health Risk |
Pathogenic |
Poikiloderma with neutropenia, Poikiloderma with neutropenia |
| RS137853973 |
USB1
|
Health Risk |
Pathogenic |
Poikiloderma with neutropenia, Poikiloderma with neutropenia |
| RS137853977 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS137853981 |
TSC2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS137853982 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS137853983 |
TSC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS137853986 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS137853987 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS137853988 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis syndrome |
| RS137853990 |
TSC2
|
Health Risk |
Likely pathogenic |
Isolated focal cortical dysplasia type II, Isolated focal cortical dysplasia type II |
| RS137853993 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS137853995 |
TSC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS137853997 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis syndrome |
| RS137853998 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis syndrome |